ethoxyresorufin has been researched along with 7-benzyloxyquinoline in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arista, L; Ashby, CR; Blaney, FE; Bonanomi, G; Braggio, S; Capelli, AM; Checchia, A; Damiani, F; Di-Fabio, R; Fontana, S; Gentile, G; Griffante, C; Hamprecht, D; Heidbreder, C; Marchioro, C; Micheli, F; Mugnaini, M; Piner, J; Ratti, E; Tarsi, L; Tedesco, G; Terreni, S; Worby, A | 1 |
Arista, L; Bertani, B; Braggio, S; Capelli, AM; Cremonesi, S; Di-Fabio, R; Gelardi, G; Gentile, G; Heidbreder, C; Marchioro, C; Micheli, F; Pasquarello, A; Provera, S; Tarsi, L; Tedesco, G; Terreni, S; Worby, A | 1 |
2 other study(ies) available for ethoxyresorufin and 7-benzyloxyquinoline
Article | Year |
---|---|
1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonists.
Topics: Animals; Cell Membrane; Computer Simulation; Drug Design; Guinea Pigs; Hexanes; Humans; Male; Models, Animal; Models, Chemical; Molecular Structure; Receptors, Dopamine D3; Stereoisomerism; Structure-Activity Relationship | 2010 |
Exploration of the amine terminus in a novel series of 1,2,4-triazolo-3-yl-azabicyclo[3.1.0]hexanes as selective dopamine D3 receptor antagonists.
Topics: Animals; Azabicyclo Compounds; Catalytic Domain; CHO Cells; Cricetinae; Cricetulus; Humans; In Vitro Techniques; Microsomes, Liver; Models, Molecular; Radioligand Assay; Rats; Receptors, Dopamine D3; Structure-Activity Relationship; Triazoles | 2010 |